Delivery Order SPE2DB20D9331-SPE2DB24FL0N2
- Not listed
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $46,683.30 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the supply of VABYSMO 6 MG/0.05 ML VIAL 0.05ML, a pharmaceutical product, with an ultimate completion date of August 9, 2024. DMS Pharmaceutical Group Inc. holds a significant indefinite delivery contract (IDC) with the DLA under the SPE2DB program,...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $7,780.55 contract is for the delivery of VABYSMO 6 MG/0.05 ML VIAL 0.05ML, a specialized pharmaceutical product. DMS Pharmaceutical Group holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the DLA to issue...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $49,795.52, is for the delivery of VABYSMO 6 mg/0.05 mL vial 0.05 mL to support the recurring medical supply needs of military health facilities worldwide. DMS Pharmaceutical Group Inc. holds a significant indefinite delivery contract (IDC) with the DLA under...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The order, valued at $48,013.50, is for the delivery of VABYSMO 6 MG/0.05 ML VIAL 0.05ML, a prescription pharmaceutical product. This delivery order is part of a larger indefinite delivery contract (IDC) awarded to DMS Pharmaceutical Group by the DLA under the SPE2DB program, which has a...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valued at $2,916.80, is for the delivery of VABYSMO 6 MG/0.05 ML VIAL 0.05ML, a specialized pharmaceutical product. The contract has an ultimate completion date of March 7, 2025. DMS Pharmaceutical Group Inc. also holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB...
- This is a $6,224.44 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The order is for the supply of VABYSMO 6 MG/0.05 ML VIAL 0.05ML, a specialized pharmaceutical product, with a period of performance through November 7, 2024. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program,...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $58,336.00, is for the delivery of VABYSMO 6 MG/0.05 ML VIAL 0.05ML, a specialized pharmaceutical product. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $499,999,999 that DMS Pharmaceutical Group holds with the DLA under the...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $2,983.44 contract is for the supply of VABYSMO 6 MG/0.05 ML SYRINGE 0.05ML, a pharmaceutical product, with a period of performance through August 6, 2025. DMS Pharmaceutical Group holds a significant Indefinite Delivery Contract (IDC) valued at $499,999,999 with the DLA under the SPE2DB...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $6,224.44 contract is for the supply of VABYSMO 6 MG/0.05 ML VIAL 0.05ML, a pharmaceutical product. This award is part of a larger $499,999,999 indefinite delivery contract (IDC) that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program. The IDC allows the DLA to issue...
- This firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Illinois. The $46,683.30 award is for the supply of VABYSMO 6 MG/0.05 ML VIAL 0.05ML, a pharmaceutical product, to fulfill the recurring medical supply needs of military health facilities. This delivery order is part of a larger single-award indefinite delivery contract (IDC) valued at up to $499,999,999 that...
- SPE2DB20D9331Indefinite Delivery Contract
- SPE2DB20D9331-SPE2DB24FL0N2Delivery Order
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $46,683.30, is for the supply of VABYSMO 6 MG/0.05 ML VIAL 0.05ML, a pharmaceutical product. The contract is not set-aside and has an ultimate completion date of February 20, 2024. DMS Pharmaceutical Group Inc. holds a significant indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to $499,999,999, which runs through December 31, 2025. This IDC allows the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items to fulfill the recurring medical supply needs of military health facilities worldwide. This contract award is one of the delivery orders issued under this larger IDC vehicle, solidifying DMS Pharmaceutical Group's position as a crucial supplier in the federal pharmaceutical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $46.7k | 1/29/24 |